Issuer · CIK 0001534120
AVTX — Avalo Therapeutics, Inc.
Recent filings
- May 7, 2026·Form 4·Other$839.4K
AVTX/Avalo Therapeutics, Inc.
VARKI PAUL · Chief Legal Officer
12conviction - May 7, 2026·Form 4·Other$377.9K
AVTX/Avalo Therapeutics, Inc.
Sullivan Christopher Ryan · Chief Financial Officer
8conviction - May 7, 2026·Form 4·Other$985.5K
AVTX/Avalo Therapeutics, Inc.
Doyle Mittie · Chief Medical Officer
18conviction - May 7, 2026·Form 4·Sell$72.5K
AVTX/Avalo Therapeutics, Inc.
Chan Mitchell · director
28conviction